Search research articles
Contact Us
Filters
Showing results (121-130 of 230) with videos related to
Page
of 23
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2010
Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrhea
Chau Dang, Nancy Lin, Beverly Moy, et al.
Annals of Surgical Oncology
|
April 22, 2009
Predictors of completion axillary lymph node dissection in patients with positive sentinel lymph nodes
Amer K Karam, Meier Hsu, Sujata Patil, et al.
The Breast Journal
|
May 22, 2012
Limited overall survival in patients with brain metastases from triple negative breast cancer
Patrick G Morris, Conleth G Murphy, Divya Mallam, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons
|
February 15, 2012
Serum N-telopeptide and bone-specific alkaline phosphatase levels in patients with osteonecrosis of the jaw receiving bisphosphonates for bone metastases
Patrick G Morris, Maurizio Fazio, Azeez Farooki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2019
Phase I Study of Intermittent High-Dose Lapatinib Alternating with Capecitabine for HER2-Positive Breast Cancer Patients with Central Nervous System Metastases
Aki Morikawa, Elisa de Stanchina, Elena Pentsova, et al.
Journal of the American Geriatrics Society
|
August 19, 2007
Identifying vulnerable older adults with cancer: integrating geriatric assessment into oncology practice
Arti Hurria, Stuart M Lichtman, Jonathan Gardes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2009
PIK3CA mutation associates with improved outcome in breast cancer
Kevin Kalinsky, Lindsay M Jacks, Adriana Heguy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2009
Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma
Darren R Feldman, Michael S Baum, Michelle S Ginsberg, et al.
American Journal of Clinical Oncology
|
December 4, 2010
Sarcomatoid-variant renal cell carcinoma: treatment outcome and survival in advanced disease
Ana M Molina, Satish K Tickoo, Nicole Ishill, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 11, 2012
Sexual functioning among endometrial cancer patients treated with adjuvant high-dose-rate intra-vaginal radiation therapy
Shari Damast, Kaled M Alektiar, Shari Goldfarb, et al.
Page
of 23
Search research articles
Search
Showing results (121-130 of 230) with videos related to
Sort By:
Page
of 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2010
Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrhea
Chau Dang, Nancy Lin, Beverly Moy, et al.
Annals of Surgical Oncology
|
April 22, 2009
Predictors of completion axillary lymph node dissection in patients with positive sentinel lymph nodes
Amer K Karam, Meier Hsu, Sujata Patil, et al.
The Breast Journal
|
May 22, 2012
Limited overall survival in patients with brain metastases from triple negative breast cancer
Patrick G Morris, Conleth G Murphy, Divya Mallam, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons
|
February 15, 2012
Serum N-telopeptide and bone-specific alkaline phosphatase levels in patients with osteonecrosis of the jaw receiving bisphosphonates for bone metastases
Patrick G Morris, Maurizio Fazio, Azeez Farooki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2019
Phase I Study of Intermittent High-Dose Lapatinib Alternating with Capecitabine for HER2-Positive Breast Cancer Patients with Central Nervous System Metastases
Aki Morikawa, Elisa de Stanchina, Elena Pentsova, et al.
Journal of the American Geriatrics Society
|
August 19, 2007
Identifying vulnerable older adults with cancer: integrating geriatric assessment into oncology practice
Arti Hurria, Stuart M Lichtman, Jonathan Gardes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2009
PIK3CA mutation associates with improved outcome in breast cancer
Kevin Kalinsky, Lindsay M Jacks, Adriana Heguy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2009
Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma
Darren R Feldman, Michael S Baum, Michelle S Ginsberg, et al.
American Journal of Clinical Oncology
|
December 4, 2010
Sarcomatoid-variant renal cell carcinoma: treatment outcome and survival in advanced disease
Ana M Molina, Satish K Tickoo, Nicole Ishill, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 11, 2012
Sexual functioning among endometrial cancer patients treated with adjuvant high-dose-rate intra-vaginal radiation therapy
Shari Damast, Kaled M Alektiar, Shari Goldfarb, et al.
Page
of 23